Epidemiological characteristics, medical costs and healthcare resource utilization of diabetes-related complications among Chinese patients with type 2 diabetes mellitus

References

• Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010 Jan;87(1):4–14. PubMed PMID: 19896746.
   PubMed Web of Science ®Google Scholar
• Duarte AA, Mohsin S, Golubnitschaja O. Diabetes care in figures: current pitfalls and future scenario. Epma J. 2018 Jun;9(2):125–131. PubMed PMID: 29896313; PubMed Central PMCID: PMCPMC5972141.
   PubMed Web of Science ®Google Scholar
• Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014 Feb;103(2):137–149. PubMed PMID: 24630390.
   PubMed Web of Science ®Google Scholar
• Weng J, Ji L, Jia W, et al. Standards of care for type 2 diabetes in China. Diabetes Metab Res Rev. 2016 Jul;32(5):442–458. PubMed PMID: 27464265; PubMed Central PMCID: PMCPMC5108436.
   PubMed Web of Science ®Google Scholar
• Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014 Mar 22;383(9922):1068–1083. PubMed PMID: 24315620; PubMed Central PMCID: PMCPMC4226760. .
   PubMed Web of Science ®Google Scholar
• Gerdtham UG, Clarke P, Hayes A, et al. Estimating the cost of diabetes mellitus-related events from inpatient admissions in Sweden using administrative hospitalization data. Pharmacoeconomics. 2009;27(1):81–90. PubMed PMID: 19178126.
   PubMed Web of Science ®Google Scholar
• Domeikiene A, Vaivadaite J, Ivanauskiene R, et al. Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania. Medicina (Kaunas). 2014;50(1):54–60. PubMed PMID: 25060205.
   PubMed Web of Science ®Google Scholar
• Kim TH, Chun KH, Kim HJ, et al. Direct medical costs for patients with type 2 diabetes and related complications: a prospective cohort study based on the Korean national diabetes program. J Korean Med Sci. 2012 Aug;27(8):876–882. PubMed PMID: 22876053; PubMed Central PMCID: PMCPMC3410234.
   PubMed Web of Science ®Google Scholar
• Tang L, Chen X, Chen H, et al. The economic burden of type 2 diabetes mellitus and its complications in the cities of China. Chinese Health Economics. 2003;22(12):21–23.
   Google Scholar
• Wang L, Zhang W, Liu H. Prevalence and risk factors of chronic complications of patients with type 2 idabetes. China Mod Doctor. 2014;52(8):31–33.
   Google Scholar
• He M, Yu X, Liu Z. The impact of diabetic complications on the costs for inpatients with diabetes mellitus. Chin J Diabetes. 2014;22(5):452–454.
   Google Scholar
• Wang Y. Study on the prevalence study of type 2 diabetes and related factors of idabetes chronic complications. Changchun: Jilin University; 2015.
   Google Scholar
• Huang Y, Vemer P, Zhu J, et al. Economic burden in Chinese patients with diabetes mellitus using electronic insurance claims data. PLoS One. 2016;11(8):e0159297. PubMed PMID: 27570976; PubMed Central PMCID: PMCPMC5003380.
   PubMed Web of Science ®Google Scholar
• Xiang H. Study on prevalence rates of hypertension and chronic diabetic complications of in-patients with diabetes. Chin J Epidemiol. 2003;24(9):819–821.
   Google Scholar
• Yi Y, Li Y, Hou A, et al. A retrospective cohort study of patients with type 2 diabetes in China: associations of hypoglycemia with health care resource utilization and associated costs. Diabetes Ther. 2018 Jun;9(3):1073–1082. PubMed PMID: 29623592; PubMed Central PMCID: PMCPMC5984912.
   PubMed Web of Science ®Google Scholar
• Mao W, Yip CW, Chen W. Complications of diabetes in China: health system and economic implications. BMC Public Health. 2019 Mar 6;19(1):269. PubMed PMID: 30841928; PubMed Central PMCID: PMCPMC6414024. .
   PubMedGoogle Scholar
• Avishai E, Yeghiazaryan K, Golubnitschaja O. Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine. Epma J. 2017 Mar;8(1):23–33. . PubMed PMID: 28620441; PubMed Central PMCID: PMCPMC5471802.
   PubMed Web of Science ®Google Scholar
• Xie F, Chan JC, Ma RC. Precision medicine in diabetes prevention, classification and management. J Diabetes Investig. 2018 Sep;9(5):998–1015. . PubMed PMID: 29499103; PubMed Central PMCID: PMCPMC6123056.
   PubMed Web of Science ®Google Scholar
• Ge S, Xu X, Zhang J, et al. Suboptimal health status as an independent risk factor for type 2 diabetes mellitus in a community-based cohort: the China suboptimal health cohort study. Epma J. 2019 Mar;10(1):65–72. PubMed PMID: 30984315; PubMed Central PMCID: PMCPMC6459451.
   PubMed Web of Science ®Google Scholar
• Adua E, Roberts P, Wang W. Incorporation of suboptimal health status as a potential risk assessment for type II diabetes mellitus: a case-control study in a Ghanaian population. Epma J. 2017 Dec;8(4):345–355. . PubMed PMID: 29209438; PubMed Central PMCID: PMCPMC5700018.
   PubMed Web of Science ®Google Scholar
• Mathioudakis N, Bashura H, Boyer L, et al. Development, implementation, and evaluation of a physician-targeted inpatient glycemic management curriculum. J Med Educ Curric Dev. 2019 Jan-Dec;6:2382120519861342. PubMed PMID: 31321305; PubMed Central PMCID: PMCPMC6630074.
   Web of Science ®Google Scholar
• Hong D, Si L, Jiang M, et al. Cost effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) inhibitors, Glucagon-Like Peptide-1 (GLP-1) receptor agonists, and Dipeptidyl Peptidase-4 (DPP-4) inhibitors: a systematic review. Pharmacoeconomics. 2019 Jun;37(6):777–818. PubMed PMID: 30854589.
   PubMed Web of Science ®Google Scholar
• Shao H, Zhai S, Zou D, et al. Cost-effectiveness analysis of dapagliflozin versus glimepiride as monotherapy in a Chinese population with type 2 diabetes mellitus. Curr Med Res Opin. 2017 Feb;33(2):359–369. PubMed PMID: 27817216.
   PubMed Web of Science ®Google Scholar
• Men P, Qu S, Luo W, et al. Comparison of lixisenatide in combination with basal insulin versus other insulin regimens for the treatment of patients with type 2 diabetes mellitus inadequately controlled by basal insulin: systematic review, network meta‐analysis and cost‐effectiveness analysis. Diabetes Obes Metab. 2019 Aug. PubMed PMID:31469217.
   Google Scholar
• Wu H, Eggleston KN, Zhong J, et al. Direct medical cost of diabetes in rural China using electronic insurance claims data and diabetes management data. J Diabetes Investig. 2019 Mar;10(2):531–538. PubMed PMID: 29993198; PubMed Central PMCID: PMCPMC6400160.
   PubMed Web of Science ®Google Scholar
• Jonsson B, Board C-A. Revealing the cost of type II diabetes in Europe. Diabetologia. 2002 Jul;45(7):S5–12. . PubMed PMID: 12136405.
   PubMed Web of Science ®Google Scholar
• American Diabetes A. Economic costs of diabetes in the U.S. In 2007. Diabetes Care. 2008 Mar;31(3):596–615. PubMed PMID: 18308683.
   PubMed Web of Science ®Google Scholar